Home › BECTON, DICKINSON AND COMPANY › BD BBL™ Modified Thayer-Martin (MTM II) Agar
BD BBL™ Modified Thayer-Martin (MTM II) Agar
BECTON, DICKINSON AND COMPANY · Model 221567 · UDI-DI 10382902215674
JTY
Prescription
1
510(k) clearances
82
Adverse events
9
Recalls
6
Facilities
Description
Plate Thayer-Martin Mod MTM II 20 Ea
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-06-03 | Remel, Inc | Reduced or no recovery of some strains of Neisseria gonorrhoeae. |
| 2022-11-21 | Becton Dickinson & Co. | Boxes contain a reduced concentration of Nicotinamide Adenine Dinucleotide and does not provide enough of the blood factors necessary to support Haemophilus growth. The reduction c |
| 2021-03-17 | Becton Dickinson & Co. | Products show heavy growth of C. albicans after 24 hours of incubation due to misformulation (expected reaction is partial inhibition after 18-48 hours incubation) and reduce the |
| 2021-03-17 | Becton Dickinson & Co. | Products show heavy growth of C. albicans after 24 hours of incubation due to misformulation (expected reaction is partial inhibition after 18-48 hours incubation) and reduce the |
| 2018-06-21 | Becton Dickinson & Co. | A portion of this lot was manufactured using Gentamicin instead of Vancomycin. Gentamicin is an inhibitory agent of Neisseria organisms. This product is a selective plated medium t |
| 2013-02-08 | Becton Dickinson & Co. | Increased levels of false positives in BD Probe Tech Neisseria gonorrhoeae Q Amplified DNA assay kits. |
| 2003-10-10 | Becton Dickinson & Co | Microbiological media may exhibit reduced colony size of bacteria, Haemophilus species. |
| 2003-10-02 | Remel, Inc | Some of the product lots exhibit no growth of quality control strains of Neisseria gonorrhoeae |
| 2002-11-18 | Becton Dickinson & Co. | Microbiological media may exhibit No Growth or reduced colony size of Haemophilus species. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.